Señales en vivo de 688068.SS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 abr 2024 @ 22:23):

Stats
Volumen de hoy	413 042
Volumen promedio	1.32M
Capitalización de mercado	2.62B
EPS	CNY0.290 ( 2023-06-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-27.14
ATR14	CNY0.0980 (0.33%)

Volumen Correlación

Largo: -0.14 (neutral)

Corto: 0.89 (strong)

Signal:(63.599) Same movement expected

Beijing Hotgen Biotech Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Beijing Hotgen Biotech Correlación - Moneda/Commodity

-0.66
( moderate negative )

-0.43
( neutral )

0.00
( neutral )

-0.46
( neutral )

-0.12
( neutral )

0.22
( neutral )

Beijing Hotgen Biotech Finanzas

Annual	2023
Ingresos:	CNY541.15M
Beneficio Bruto:	CNY541.15M (100.00 %)
EPS:	CNY0.340

FY	2023
Ingresos:	CNY541.15M
Beneficio Bruto:	CNY541.15M (100.00 %)
EPS:	CNY0.340

FY	2022
Ingresos:	CNY3.56B
Beneficio Bruto:	CNY1.91B (53.71 %)
EPS:	CNY10.55

FY	2021
Ingresos:	CNY5.37B
Beneficio Bruto:	CNY3.20B (59.54 %)
EPS:	CNY35.14

Financial Reports:

No articles found.

Beijing Hotgen Biotech

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. The company was founded in 2005 and is based in Beijing, China.